IFP Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

IFP Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	-$7.41K	–	3048
2019 Q4	$9K	Hold	100	–	–	﹤0.01%	1983
2019 Q3	$8K	Buy	+100	New	+$8.12K	﹤0.01%	2188
2019 Q1	–	Sell	-200	Closed	-$17K	–	3564
2018 Q4	$17K	Buy	+200	New	+$19.3K	﹤0.01%	2225
2018 Q2	–	Sell	-22	Closed	-$2K	–	4095
2018 Q1	$2K	Hold	22	–	–	﹤0.01%	3560
2017 Q4	$2K	Hold	22	–	–	﹤0.01%	3611
2017 Q3	$2K	Hold	22	–	–	﹤0.01%	3814
2017 Q2	$2K	Hold	22	–	–	﹤0.01%	3788
2017 Q1	$3K	Hold	22	–	–	﹤0.01%	3571
2016 Q4	$2K	Buy	+22	New	+$2.3K	﹤0.01%	3692
2016 Q1	–	Sell	-50	Closed	-$8K	–	3550
2015 Q4	$8K	Buy	+50	New	+$7.3K	﹤0.01%	2717

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

IFP Advisors's TARO Position: Q1 2020 in Review

IFP Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 100 shares — an estimated $7.41K sold.

IFP Advisors first reported a position in TARO in Q4 2015 and held it in 10 quarters. The position peaked at $17K in Q4 2018. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

IFP Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
IFP Advisors sold 100 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $7.41K.
IFP Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 10 quarters.
IFP Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $17K in Q4 2018.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on IFP Advisors's 13F filing for Q1 2020, filed 12 May 2020.